Anti‐tumoural activity of the G‐quadruplex ligand pyridostatin against BRCA1/2‐deficient tumours
Abstract The cells with compromised BRCA1 or BRCA2 (BRCA1/2) function accumulate stalled replication forks, which leads to replication‐associated DNA damage and genomic instability, a signature of BRCA1/2‐mutated tumours. Targeted therapies against BRCA1/2‐mutated tumours exploit this vulnerability...
Main Authors: | , , , , , , , , , , , , |
---|---|
פורמט: | Article |
שפה: | English |
יצא לאור: |
Springer Nature
2022-02-01
|
סדרה: | EMBO Molecular Medicine |
נושאים: | |
גישה מקוונת: | https://doi.org/10.15252/emmm.202114501 |